This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parker, R. A.
Right arrow Articles by Reimann, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parker, R. A.
Right arrow Articles by Reimann, K. A.

 Previous Article  |  Next Article 

Journal of Virology, November 2001, p. 11234-11238, Vol. 75, No. 22
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.22.11234-11238.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Variability of Viral Load in Plasma of Rhesus Monkeys Inoculated with Simian Immunodeficiency Virus or Simian-Human Immunodeficiency Virus: Implications for Using Nonhuman Primate AIDS Models To Test Vaccines and Therapeutics

Robert A. Parker,1,* Meredith M. Regan,1 and Keith A. Reimann2

Biometrics Center1 and Division of Viral Pathogenesis2, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215

Received 8 May 2001/Accepted 13 August 2001

Viral RNA level in plasma is a sensitive experimental endpoint for evaluating the efficacy of AIDS vaccines or therapies in nonhuman primates. By quantifying viral RNA in the plasma of 77 rhesus monkeys for 10 weeks after inoculation with simian-human immunodeficiency virus 89.6P (SHIV-89.6P) or simian immunodeficiency virus mac 251 (SIVmac 251), we estimated variability in three viral load (VL) measures: peak VL, the postacute set point VL, and VL decline from peak. Such estimates of biological variability are essential for determining the number of animals needed per group and may be helpful for selecting the most appropriate measure to use as the experimental endpoint. Peak VL was positively correlated with set point VL for both viruses. Variability (standard deviation) was substantially higher in monkeys infected with SIVmac 251 than in those infected with SHIV-89.6P for set point VL and VL decline. The variability of peak VL was less than one-half that of set point VL variability and only about two-thirds of that of VL decline, implying that the same treatment-related difference in peak VL could be detected with fewer animals than set point VL or VL decline. Thus, differences in VL variability over the course of infection and between viruses need to be considered when designing studies using the nonhuman primate AIDS models.

* Corresponding author. Mailing address: Biometrics Center/E-GZ814, BI-Deaconess Medical Center, 330 Brookline Ave., Boston, MA 02215. Phone: (617) 667-4819. Fax: (617) 667-5953. E-mail: robert_parker{at}caregroup.harvard.edu.

Journal of Virology, November 2001, p. 11234-11238, Vol. 75, No. 22
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.22.11234-11238.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Choi, E. I., Reimann, K. A., Letvin, N. L. (2008). In Vivo Natural Killer Cell Depletion during Primary Simian Immunodeficiency Virus Infection in Rhesus Monkeys. J. Virol. 82: 6758-6761 [Abstract] [Full Text]  
  • Wilson, D. P., Mattapallil, J. J., Lay, M. D. H., Zhang, L., Roederer, M., Davenport, M. P. (2007). Estimating the Infectivity of CCR5-Tropic Simian Immunodeficiency Virus SIVmac251 in the Gut. J. Virol. 81: 8025-8029 [Abstract] [Full Text]  
  • Dioszeghy, V., Benlhassan-Chahour, K., Delache, B., Dereuddre-Bosquet, N., Aubenque, C., Gras, G., Le Grand, R., Vaslin, B. (2006). Changes in Soluble Factor-Mediated CD8+ Cell-Derived Antiviral Activity in Cynomolgus Macaques Infected with Simian Immunodeficiency Virus SIVmac251: Relationship to Biological Markers of Progression. J. Virol. 80: 236-245 [Abstract] [Full Text]  
  • Hel, Z., Tsai, W.-P., Tryniszewska, E., Nacsa, J., Markham, P. D., Lewis, M. G., Pavlakis, G. N., Felber, B. K., Tartaglia, J., Franchini, G. (2006). Improved Vaccine Protection from Simian AIDS by the Addition of Nonstructural Simian Immunodeficiency Virus Genes. J. Immunol. 176: 85-96 [Abstract] [Full Text]  
  • Stewart, M., Desport, M., Hartaningsih, N., Wilcox, G. (2005). TaqMan Real-Time Reverse Transcription-PCR and JDVp26 Antigen Capture Enzyme-Linked Immunosorbent Assay To Quantify Jembrana Disease Virus Load during the Acute Phase of In Vivo Infection. J. Clin. Microbiol. 43: 5574-5580 [Abstract] [Full Text]  
  • Muhl, T., Krawczak, M., ten Haaft, P., Hunsmann, G., Sauermann, U. (2002). MHC Class I Alleles Influence Set-Point Viral Load and Survival Time in Simian Immunodeficiency Virus-Infected Rhesus Monkeys. J. Immunol. 169: 3438-3446 [Abstract] [Full Text]  
  • Fuller, C. L., Choi, Y. K., Fallert, B. A., Capuano, S. III, Rajakumar, P., Murphey-Corb, M., Reinhart, T. A. (2002). Restricted SIV Replication in Rhesus Macaque Lung Tissues During the Acute Phase of Infection. Am. J. Pathol. 161: 969-978 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»